IP Library Granted Patent US 11,268,951
Granted Patent B2
US 11,268,951 · App. 16/133,828 · Granted Mar 8, 2022

CHO host cell protein assay

Inventor: Olaf Stamm (Erkrath, DE)
Assignee: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
G01N33/541C07K16/00C07K16/18G01N33/6803C07K2317/10C07K2317/11C07K2317/20C07K2317/23
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,268,951
App. No.
16/133,828
Granted
Mar 8, 2022
Kind
B2
Abstract

The present invention provides compositions, kits, and methods for the detection of host cell proteins (HCPs) in biological samples. In some embodiments, the present invention utilizes immunization of aves hosts with proteins derived from non-aves host cells to produce aves antibodies specific for non-aves HCPs.

Claims (15)

1. A method of detecting an amount of one or more host cell proteins (HCPs) in a sample comprising:

(a) exposing the sample to a first HCP-specific antibody under conditions sufficient to allow binding of the first HCP-specific antibody to the one or more HCP proteins present in the sample and formation of antibody-HCP protein complexes;

(b) processing the sample to remove uncomplexed HCP-specific antibodies and HCP proteins;

(c) detecting an amount of the antibody-HCP protein complexes,

wherein the first HCP-specific antibody is produced in an aves host and is an IgY isotype, and

wherein the first HCP-specific antibody is capable of detecting at least 85% of the HCP proteins present in the then sample.

2. The method of claim 1 , wherein detecting the amount of the antibody-HCP protein complexes comprises:

(i) exposing the sample to a second HCP-specific antibody under conditions sufficient to allow binding of the second HCP-specific antibody to the one or more HCP proteins in the antibody-HCP protein complexes; and

(ii) detecting an amount of the second HCP-specific antibody, wherein the second HCP-specific antibody comprises a detectable label.

3. The method of claim 2 , wherein the detectable label is biotin, an enzyme label, or a fluorescent label.

4. The method of claim 1 , wherein the aves host is a chicken.

5. The method of claim 1 , wherein the HCPs are derived from a non-aves host.

6. The method of claim 5 , wherein the non-aves host is a mammalian host selected from the group consisting of hamsters, mice, rats, rabbits, and humans.

7. The method of claim 1 , wherein the HCPs are derived from a CHO cell.

8. The method of claim 1 , wherein the HCP-specific antibody is a polyclonal antibody.

Assignments (3)
SECURITY INTEREST Recorded Dec 13, 2024
From: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 069582/0600 →
SECURITY INTEREST Recorded Apr 21, 2021
From: CHARLES RIVER LABORATORIES, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 055994/0202 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2018
From: STAMM, OLAF
To: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Reel/Frame 046896/0967 →
Continuity (2)
Provisional Application 62561033 · Sep 20, 2017
Related Publication 20190086397A1 · Mar 21, 2019